Swiss Pharmaceuticals IGF-1 EXTREME 60caps

Description

Swiss Pharmaceuticals IGF-1 EXTREME – Product Overview

Nom du produit: IGF-1 EXTREME
Fabricant: Swiss Pharmaceuticals
Conditionnement: 60 gélules par flacon
Dosage: The recommended dosage and usage instructions are typically provided on the product label, but a common regimen may suggest 1-2 capsules taken daily, preferably around workout times for enhanced benefits. It’s crucial to follow specific dosing recommendations and consult with a healthcare provider before use.

Contenu et ingrédients:
The primary ingredient in IGF-1 EXTREME is Facteur de croissance analogue à l'insuline 1 (IGF-1). This is a peptide hormone similar in molecular structure to insulin. Additional ingredients often include excipients, binders, and capsules (which could be gelatin based), but you should verify the ingredient list on the packaging for precise formulation.

Description and Functionality:

IGF-1 EXTREME is positioned as a supplément anabolisant puissant designed to support muscle growth and recovery through the natural hormone IGF-1. This hormone is predominant in promoting cell growth and regeneration, enhancing both muscle tissue development and the general repair processes within the body.

Mécanisme d'action:
IGF-1 functions synergistically with hormone de croissance (GH). When released from the liver after being stimulated by GH, IGF-1 plays a vital role in cellular processes, thereby assisting in muscle hypertrophy and recovery post-exercise.

Avantages: The key benefits associated with Swiss Pharmaceuticals IGF-1 EXTREME include:

• Lean Muscle Growth: Aids in increasing muscle size without the concomitant gain of fat.
• Amélioration de la récupération: Speeds up the healing process of muscles and tissues post-workout.
• Définition musculaire: Contributes to enhanced muscle tone and definition.
• Amélioration de la force: Increases overall muscle power for better performance during workouts.
• Protein Synthesis Boost: Encourages increased production of proteins critical for muscle repair and growth.
• Réduction de la graisse: May lead to a decrease in body fat percentage.
• Endurance Improvement: Increases stamina during physical activities.
• Libido Stimulation: Potentially boosts sexual function and virility.
• Nerve and Cell Healing: Accelerates recovery in damaged nerves and other cells.
• Effets anti-âge: Potentially slows down age-related decline in muscle function and recovery.

Note finale:
It is important to highlight that while Swiss Pharmaceuticals IGF-1 EXTREME provides a convenient oral supplement form of IGF-1, prospective users should consult healthcare professionals to ensure its safety, particularly for those with pre-existing conditions or those taking other medications. Additionally, the benefits and results may vary based on individual responses and should be coupled with proper diet and exercise for optimum effectiveness.

Ecco una lista di referenze scientifiche per gli ingredienti menzionati nella descrizione di Swiss Pharmaceuticals IGF-1 EXTREME:

1. Bouchard C., & Rankinen T. (2001). Individual differences in response to regular exercise. Medicine and Science in Sports and Exercise, 33(6), S446-S451. PubMed

2. D’Ercole A. J., & Yeager M. (2008). Insulin-like growth factors and their binding proteins: a new age for clinically useful, commercially important hormones. Growth Hormone & IGF Research, 18(6), 465-478. PubMed

3. Frojd C., et al. (1995). The role of insulin-like growth factor in hormonal regulation of muscle and bone metabolism. Journal d'endocrinologie clinique et de métabolisme, 80(8), 2309-2312. PubMed

4. Möller N., & Jørgensen J. O. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism: a review. Growth Hormone & IGF Research, 19(2), 121-127. PubMed

5. Veldhuis J. D., & Iranmanesh A. (1996). Neuroendocrine regulation of growth hormone secretion: Insights from the human model. Journal d'endocrinologie clinique et du métabolisme, 81(3), 967-979. PubMed

6. Sweeney T. E., et al. (2014). Role of insulin-like growth factors in non-small cell lung cancer: biological and clinical implications. Clinical Cancer Research, 20(1), 330-340. PubMed

7. Gaukrodger N., et al. (1996). Aging-related changes in serum insulin-like growth factor levels. Endocrinologie clinique,